Kristina Ruuth

Research group Matthew Francis

Research projects

Head of research

Title

Date sorteringsordning

Hallberg, Bengt

Functional characterization of ExoS, its activation and the functional effects of ExoS on cell signalling in vivo.

09/05/2012

Publications

Author

Title

Year sorteringsordning

Fulltext

Amer, Ayad
Gurung, Jyoti
Costa, Tiago; et al.

YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis
Frontiers in Cellular and Infection Microbiology, 6

2016

Download

Guan, J.
Tucker, E. R.
Wan, H.; et al.

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
Disease Models and Mechanisms, 9(9): 941-952

2016

Download

Fransson, Susanne
Hansson, Magnus
Ruuth, Kristina; et al.

Intragenic Anaplastic Lymphoma Kinase (ALK) Rearrangements: Translocations as a Novel Mechanism of ALK Activation in Neuroblastoma Tumors
Genes, Chromosomes and Cancer, 54(2): 99-109

2015

-

Umapathy, Ganesh
El Wakil, Abeer
Witek, Barbara; et al.

The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma
Science Signaling, 7(349): ra102-

2014

-

Chand, Damini
Yamazaki, Yasuo
Ruuth, Kristina; et al.

Cell and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma
Disease models & mechanisms, 6(2): 373-382

2013

Download

Sattu, Kamaraj
Hochgräfe, Falko
Wu, Jianmin; et al.

Phosphoproteomic analysis of anaplastic lymphoma kinase (ALK) downstream signaling pathways identifies signal transducer and activator of transcription 3 as a functional target of activated ALK in neuroblastoma cells
The FEBS Journal, 280(21, Special Issue): 5269-5282

2013

-

Schönherr, Christina
Ruuth, Kristina
Kamaraj, Sattu; et al.

Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells
Oncogene, 31(50): 5193-5200

2012

-

Schönherr, Christina
Ruuth, Kristina
Yamazaki, Yasuo; et al.

Activating ALK mutations found in neuroblastoma are inhibited by Crizotinib and NVP-TAE684
Biochemical Journal, 440: 405-413

2011

-

Martinsson, Tommy
Eriksson, Therese
Abrahamsson, Jonas; et al.

Appearance of the novel activating F1174S ALK mutation in neuroblastoma correlates with aggressive tumour progression and unresponsiveness to therapy
Cancer Research, 71(1): 98-105

2011

-

Blomberg, Jeanette
Höglund, Andreas
Eriksson, David; et al.

Inhibition of cellular FLICE-like inhibitory protein abolishes insensitivity to interferon-α in a resistant variant of the human U937 cell line
Apoptosis (London), 16(8): 783-794

2011

-


Page Editor: Selma Grönlund

Print page